1. Home
  2. CGNX vs GKOS Comparison

CGNX vs GKOS Comparison

Compare CGNX & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cognex Corporation

CGNX

Cognex Corporation

HOLD

Current Price

$53.00

Market Cap

6.0B

Sector

Industrials

ML Signal

HOLD

Logo Glaukos Corporation

GKOS

Glaukos Corporation

HOLD

Current Price

$115.41

Market Cap

6.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CGNX
GKOS
Founded
1981
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.0B
6.9B
IPO Year
1994
2015

Fundamental Metrics

Financial Performance
Metric
CGNX
GKOS
Price
$53.00
$115.41
Analyst Decision
Buy
Strong Buy
Analyst Count
12
14
Target Price
$55.08
$133.07
AVG Volume (30 Days)
2.8M
718.9K
Earning Date
05-13-2026
05-14-2026
Dividend Yield
0.63%
N/A
EPS Growth
9.68
N/A
EPS
0.68
N/A
Revenue
N/A
$507,442,000.00
Revenue This Year
$9.92
$23.29
Revenue Next Year
$8.78
$27.74
P/E Ratio
$78.82
N/A
Revenue Growth
N/A
32.33
52 Week Low
$22.67
$73.16
52 Week High
$59.88
$130.23

Technical Indicators

Market Signals
Indicator
CGNX
GKOS
Relative Strength Index (RSI) 59.77 48.33
Support Level $41.11 $104.72
Resistance Level $59.11 $130.23
Average True Range (ATR) 2.15 4.90
MACD -0.57 0.08
Stochastic Oscillator 19.33 61.75

Price Performance

Historical Comparison
CGNX
GKOS

About CGNX Cognex Corporation

Cognex Corp provides machine vision products that help automate manufacturing processes. The firm's products include vision software, vision systems, vision sensors, and ID products. Vision software combines vision tools with a customer's cameras and peripheral equipment and can help with several vision tasks, including part location, identification, measurement, and robotic guidance. Vision systems combine a camera, processor, and vision software into a single package. Vision sensors deliver simple, low-cost solutions for common vision applications, such as checking the size of parts. ID products read codes that have been applied to items during the manufacturing process. Cognex generates the maximum proportion of its sales in the United States and Europe.

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

Share on Social Networks: